Clinical Trial Update: Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers [NA]

View source ↗

Summary

A multi-cancer prospective study evaluating double-positive circulating cells (CD45+ tumor marker) in several types of metastatic cancers; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Carcinoma
• Cutaneous Melanoma
• Endometrial Adenocarcinoma
• Germ Cell Tumor
• Prostate Adenocarcinoma
• Renal Cell Carcinoma
• Soft Tissue Sarcoma
• Urothelial Carcinoma

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Urothelial Carcinoma, Renal Cancer | NA | Status: RECRUITING